School of Medicine
Showing 501-600 of 2,414 Results
-
Anthony DuBose
Clinical Associate Professor, Medicine - Primary Care and Population Health
Current Research and Scholarly InterestsSoft tissue musculoskeletal injuries with focus on repetitive strain injuries
-
Tamara Dunn
Clinical Associate Professor, Medicine - Hematology
BioDr. Tamara Dunn is a clinical associate professor in the Division of Hematology at the Stanford University School of Medicine. She is a clinician with a special interest in medical education, diversity, equity, and inclusion. Specifically, she is committed to improving workforce diversity and creating inclusive workplaces. She is currently the Program Director for the Stanford Hematology/Oncology Fellowship and one of the Associate Chairs of Diversity and Inclusion for the Department of Medicine at Stanford. She is a member of the inaugural American Society of Hematology (ASH) Ambassador Cohort and serves on the ASH Women in Hematology committee, which she co-chairs. She is on the steering committee and is a mentor for Stanford’s Leadership Education in Advancing Diversity (LEAD) program. She takes pride in treating underserved veterans at the Palo Alto Veterans Hospital, where she sees both classical and malignant hematology. Outside of medicine she enjoys singing, dancing, sports (Go Chiefs! Go Warriors!), board games, movies, and spending time with friends and family including her 3 young children, spouse, and energetic vizsla Casey.
-
Mary Laurence Dunne
Affiliate, Medicine - Primary Care and Population Health
BioDr. Mimi Dunne is a physician leader in palliative and emergency medicine with a longstanding commitment to innovation in end-of-life care and medical education. A 2019-2020 Stanford Distinguished Careers Institute Fellow, Dr. Dunne has co-taught MED 296: Being Mortal at Stanford University School of Medicine.
A graduate of Saint Louis University School of Medicine, she completed postgraduate training at the University of Chicago, certification in Mindfulness-Based Stress Reduction at the University of Massachusetts, and is board-certified in both Emergency Medicine and Hospice and Palliative Medicine. As Medical Director of Hudson Valley Hospice, she founded the region’s first palliative care program in 2001.
Her scholarly work spans emergency medicine, palliative medicine, and global health, and she has authored studies, articles, and book chapters in these fields. She currently serves as an advisor to the African Center for Research in End of Life Care in Rwanda and to Bulamu Health Care in Uganda. -
Nikki Duong, MD
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
Current Research and Scholarly InterestsMy research interests focus on quality improvement and patient reported outcomes in people with cirrhosis. I also have interests in expanding our breadth of knowledge in caring for patients with gastrointestinal and liver disorders who identify as a sexual and gender minority.
-
George Duran
Cancer Biologist and Laboratory Manager, Medicine - Med/Oncology
Current Role at StanfordCancer biologist specializing in the development of novel chemotherapeutic agents and in mechanisms of drug resistance. Current research ranges from molecular studies to further understand the heterogeneity of T-cell lymphomas, to translational studies of molecular determinants of therapeutic response, and clinical trials that use the body’s immune system to fight cancer cells.
Original research contributions have resulted in the authorship of over eighty publications. -
Benjamin J. Durant, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Benjamin Durant is a board-certified family medicine doctor at Stanford Health Care and a clinical assistant professor in the Department of Medicine, Division of Primary Care and Population Health at Stanford University School of Medicine.
Dr. Durant provides complete primary care for people of all ages, with a strong focus on health equity and supporting underserved communities. His clinical interests include outpatient care, prenatal and reproductive health, and treating substance use disorders. He has extensive experience in street medicine and mobile outreach to care for people experiencing homelessness. Dr. Durant takes a trauma-informed, relationship-based approach, building trust and meeting patients where they are.
His academic and service work has focused on improving access to care, training health care workers in under-resourced areas, and helping patients who face challenges like poverty, housing insecurity, or limited access to services. Dr. Durant’s approach to medicine is built on dignity, trust, and long-term relationships. He is committed to understanding and addressing the social factors that affect health. He has also volunteered internationally in Kenya and Haiti. -
Asiri Ediriwickrema MD, PhD
Assistant Professor of Medicine (Hematology)
BioAsiri Ediriwickrema, MD, PhD, is a physician-scientist who leads a systems hematology laboratory at Stanford and directs a clinical practice focused on myelodysplastic neoplasms and clonal hematopoiesis. Asiri leads a research group that studies hematopoiesis—the complex process by which hematopoietic stem cells generate the diverse blood cells essential for health throughout life. We study how individual blood cells change during aging and cancer development, with particular focus on how dysregulation of this process leads to cytopenias and hematologic malignancies.
Our work integrates expertise spanning clinical medicine, functional hematology, molecular and cellular biology, genomics, bioinformatics, and machine learning. By combining advanced experimental techniques with computational approaches, we examine blood cell development and function at single-cell resolution. We aim to identify early cellular changes in cancer development, map how stem cells interact within their tissue environments, and develop computational tools that predict stem cell behavior and disease progression. Our goal is to translate these efforts into improved diagnostics and precision therapeutic strategies for patients with blood disorders and malignancies.
Dr. Ediriwickrema earned his undergraduate degree in Engineering from the Massachusetts Institute of Technology, his MD (Cum Laude) from Yale University, and his PhD from Stanford University. He completed his residency in Internal Medicine and fellowship in Hematology at Stanford, where he also conducted his doctoral and postdoctoral research in the laboratory of Dr. Ravi Majeti. His research identified novel populations of multipotent progenitor cells in normal hematopoiesis and leukemia stem cells in acute myeloid leukemia (AML). -
Zachary Edmonds, MD, MBA
Academic Staff - Hourly - CSL, Medicine - Cardiovascular Medicine
Adjunct Professor, Medicine - Cardiovascular MedicineBioAdjunct Professor of Medicine | Cardiovascular Medicine | Stanford Medicine
Seasoned clinician with a proven track record of mentoring medtech entrepreneurs and early stage companies in the development of life changing technologies. As the Associate Director of the PAMF Hospital Medicine service line he co-leads a team of 30 physicians across 3 community hospitals in the Bay Area. When not seeing patients, he serves as the Chief Medical Officer at Fogarty Innovation where he mentors a variety of early stage companies. As an Adjunct Professor of Medicine at Stanford he works closely with the Biodesign group to teach and mentor students and Biodesign fellows. He co-teaches the Biodesign Innovation graduate course which is offered to Stanford graduate students in the school of medicine, school of engineering and the graduate school of business each winter and spring quarter. Zach holds an MD from the UCLA School of Medicine and an MBA from the UCLA Anderson School of Management. He completed Internal Medicine Residency and the Biodesign Fellowship at Stanford University. -
Katharine Sears Edwards
Clinical Associate Professor, Medicine - Cardiovascular Medicine
Clinical Assistant Professor (By courtesy), Psychiatry and Behavioral SciencesCurrent Research and Scholarly InterestsPotential impact of brief behavioral interventions to improve adjustment, coping, medical adherence, and cardiovascular health among cardiac patients.
Psychosocial challenges of patients with spontaneous coronary artery dissection (SCAD).
Assessment and training in evidence-based psychological therapies. -
Goar Egoryan
Clinical Assistant Professor, Medicine
BioI am a Clinical Assistant Professor and oncology hospitalist in the Division of Hospital Medicine at Stanford University School of Medicine. I care for patients with solid tumors admitted with complex, high-acuity conditions, including cancer-related complications, treatment toxicities, infections, malnutrition, and end-of-life care, making complex clinical decisions and navigating high-stakes situations with patients and families, often integrating input from multiple consulting teams.
I received my Doctor of Medicine degree summa cum laude from Novosibirsk State Medical University and completed a two-year rheumatology fellowship in Russia, a specialty defined by multiorgan complexity and the search for systemic connections. I later moved to the United States, where I completed an internal medicine residency at Ascension Saint Francis Hospital in Evanston, IL. During residency, I was named Intern of the Year, received the Great Catch Award for identifying and correcting a patient care error, served as Chief Resident in my third year, and contributed to over 20 publications, half as first author.
My early training in rheumatology, a field centered on systemic disease and pattern recognition, continues to shape how I approach complex illness and informs my interest in integrative medicine. In my current practice, I already incorporate elements of integrative medicine by considering lifestyle, behavioral, and psychosocial factors alongside medical management when caring for complex patients. My current academic interest centers on bringing evidence-based integrative medicine into the inpatient oncology setting. I was recently awarded a Stanford SMART-HM grant to pursue formal training in integrative medicine and to develop a care model that addresses the needs of hospitalized oncology patients beyond disease-directed treatment, including symptom burden and psychological distress. My long-term aim is to expand this approach to broader hospitalized populations while improving patient experience and clinical outcomes. -
Shirit Einav
Professor of Medicine (Infectious Diseases) and of Microbiology and Immunology
On Leave from 06/06/2026 To 09/05/2026Current Research and Scholarly InterestsOur basic research program focuses on understanding the roles of virus-host interactions in viral infection and disease pathogenesis. This program is combined with translational efforts to apply this knowledge for the development of broad-spectrum host-centered antiviral approaches to combat emerging viral infections, including dengue, encephalitic alphaviruses, coronaviruses, and filoviruses, and means to predict disease progression.
-
Matthew A. Eisenberg
Clinical Assistant Professor (Affiliated), Computational Medicine
BioDr. Matthew A. Eisenberg joined Stanford Health Care in early 2013 and is the Medical Informatics Director for Analytics & Innovation with a focus on interoperability and health information exchange, regulatory reporting, health care analytics, patient reported outcomes and other uses of technology to meet our strategic initiatives.
Dr. Eisenberg is board certified in Pediatrics and Clinical Informatics. He is a Clinical Assistant Professor (Affiliated) in the Stanford Center for Biomedical Informatics Research at the Stanford University School of Medicine and he serves as the Stanford Health Care site director for the Stanford Clinical Informatics Fellowship Program. He previously held the position of Clinical Assistant Professor in Pediatrics at the University of Washington School of Medicine. He is a current member of the eHealth Exchange Coordinating Committee, a Sequoia Project Board member and serves as the current chair of the Epic Care Everywhere Network Governing Council. He is a member of the Carequality Advisory Council (past co-chair) and a member of IHE USA Implementation Committee. He is a Fellow of the American Academy of Pediatrics and a member of the American Medical Informatics Association and their Clinical Informatics Community. -
Chiazotam Ekekezie
Clinical Assistant Professor, Medicine - Gastroenterology & Hepatology
BioPrior to Stanford, Dr Ekekezie completed internal medicine training and chief residency at Brown University. She moved to Stanford for GI and hepatology fellowship, and served as a chief fellow in her final year. After fellowship, she stayed on joining as a Clinical Assistant Professor and Associate Program Director for the GI fellowship program. She has presented nationally and internationally on topics related to medical education, psychological safety, and inclusion.
Clinically, Dr Ekekezie welcomes seeing patients with a diverse range of GI-related issues as part of Stanford’s general GI group. She is dedicated to advancing a career in academic medicine that is balanced on her “core-four” pillars: humanism-centered patient care, community-engaged advocacy, service-oriented leadership, and mentoring the next generation of clinicians. She has received numerous awards for excellence in patient care, professionalism, communication, and collaborative consultation, as well as for her skills as an effective leader, mentor, and educator. -
Vanessa El Kamari
Instructor, Medicine - Infectious Diseases
BioVanessa El Kamari, MD, is a physician-scientist in the Division of Infectious Diseases and Geographic Medicine at Stanford University and a member of the David Relman Laboratory. Her research investigates how host–microbe interactions in the small intestine regulate mucosal immunity, barrier integrity, and systemic inflammation in autoimmune and inflammatory diseases.
Her current studies use non-invasive sampling of the small intestine in conditions such as celiac disease, multiple sclerosis, and environmental enteropathy. She applies an integrative, multi-omic approach—combining microbiology, immunology, molecular biology, and computational biology—to define spatial immune–microbial networks along the human gut.
Before joining Stanford, Dr. El Kamari’s research focused on inflammation and immune activation in chronic HIV infection, where she identified gut barrier dysfunction as a key driver of systemic inflammation and cardiometabolic complications. She also led intervention studies targeting immune activation and endothelial dysfunction in HIV, work that laid the foundation for her current efforts to apply similar mechanistic approaches to autoimmune and inflammatory disorders. -
Menashe Elazar
Sr. Research Scientist - Basic Life, Medicine - Med/Gastroenterology and Hepatology
Current Role at StanfordSenior Research Scientist
-
Samer Eldika
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioDr. Eldika received his medical education at the American University of Beirut. He completed his General Gastroenterology Fellowship at the State University of New York in Buffalo and Advanced Endoscopy Fellowship at the University of Virginia. At Ohio State University, he served as the Director of Interventional Endoscopy and Endoscopic Quality. His time at Ohio State University contributed to the growth and maturity of his experience and skills in interventional endoscopy. During his tenure there, he played a major role in building the program of interventional endoscopy in general, as well as interventional endoscopy for the pediatric age group, and the endoscopic quality program. Over the years, he was involved in training several gastroenterology fellows and interventional endoscopists. He recently joined Stanford University where he continues to practice interventional endoscopy and train fellows.
He is a board-certified Gastroenterologist with clinical interests in pancreaticobiliary diseases, gastrointestinal neoplasia, and related interventional endoscopic procedures. As an endoscopist, he has extensive experience in performing a variety of interventional endoscopic procedures. These procedures include endoscopic ultrasound (EUS)-guided procedures like fine needle aspiration/biopsy, injections, fiducial placement, pseudocyst drainage/necrosectomy, biliary drainage, gastrojejunostomy, transgastric ERCP, and needle-based confocal endomicroscopy for the evaluation of pancreatic cystic lesions. He also performs endoscopic retrograde cholangiopancreatography (ERCP), endoscopic mucosal resection, enteral and stenting, enteral feeding tube placement, as well as deep enteroscopy.
His research interest evolves around interventional endoscopy, more specifically in the evaluation of pancreatic cystic lesions. Dr. Eldika has received multiple awards in his career, his most recent one being the “Reviewer Award, April 2020,” for his superior contributions to the journal of Gastrointestinal Endoscopy, both through completing high numbers of reviews and for submitting the highest quality of work.
Dr. Eldika is a fellow of the American Society of Gastrointestinal Endoscopy. He is a member of the American Gastroenterological Association, American College of Gastroenterology, and American Pancreatic Association.
When not working Dr. Eldika enjoys reading, listening to music, watching sports and walking in nature. -
Jennie Lisabeth Ellison
Casual Employee, Medicine
Current Role at StanfordGrant & Communications Writer
-
Hany Elmariah
Associate Professor of Medicine (Blood and Marrow Transplantation and Cellular Therapy)
BioDr. Hany Elmariah is an Associate Professor in the Division of Blood and Marrow Transplantation and Cellular Therapy at Stanford University. Dr. Elmariah earned his MD and his MS in Biomedical Engineering at the University of Florida. He completed an Internal Medicine Residency at Duke University. Dr. Elmariah then completed a Hematology and Oncology Fellowship at Johns Hopkins University, where he also served as Chief Fellow. He then was a faculty member at the Moffitt Cancer Center before joining the faculty at Stanford University. Dr. Elmariah's clinical focus is allogeneic transplant for myeloid malignancies including acute myeloid leukemia, myelodysplastic syndromes, and myeloproliferative neoplasms. His research is focused on haploidentical and mismatched unrelated donor blood and marrow transplantation and novel cellular therapies for myeloid malignancies.
-
Michelle Yixiao Engle, MD
Clinical Assistant Professor, Medicine - Primary Care and Population Health
BioDr. Michelle Engle grew up in Virginia, though she has also lived in China and Canada. She moved to California for medical training and quickly grew attached to the Bay Area. She is board-certified in family medicine and palliative medicine, providing holistic care to patients of all ages.
Her hobbies include barre, board games, escape rooms, cooking, and rock climbing. -
Edgar Engleman
Professor of Pathology and of Medicine (Immunology and Rheumatology)
On Leave from 07/01/2025 To 06/30/2026Current Research and Scholarly InterestsDendritic cells, macrophages, NK cells and T cells; functional proteins and genes; immunotherapeutic approaches to cancer, autoimmune disease, neurodegenerative disease and metabolic disease.
-
David Epstein
Clinical Assistant Professor, Medicine - Infectious Diseases
Current Research and Scholarly Interestspulmonary infections, bronchiectasis, and suppurative lung diseases complicating BMT and CAR-T; bronchiectasis; NTM infections
-
Berrin Er
Affiliate, Medicine - Med/Pulmonary, Allergy & Critical Care Medicine
Visiting Scholar, Medicine - Med/Pulmonary, Allergy & Critical Care MedicineBioBerrin Er, M.D., is a physician and visiting scholar in the Division of Pulmonary, Allergy, and Critical Care Medicine. She graduated from Istanbul University Faculty of Medicine and completed her residency training as well as a critical care fellowship at Hacettepe University, Ankara, Turkey.
As a visiting researcher, Dr. Er integrates her clinical expertise with advanced computational methods. Her research focuses on interstitial lung diseases, with an emphasis on radiomics, and on analyzing diverse datasets related to respiratory diseases using data-driven approaches. Her work aims to enhance disease characterization and support clinical decision-making.
www.linkedin.com/in/berrin-er-b3214999 -
Arvin Eslami
Research Associate, Medicine - Med/Immunology & Rheumatology
Current Role at StanfordResearch Associate in the Division of Immunology & Rheumatology at Stanford University School of Medicine.
Responsibilities include supporting immunotherapy and cellular therapy research (CAR-T and TIL), clinical data organization, database management, and contribution to manuscripts, systematic reviews, and meta-analyses.
July 2025 – Present -
Ali Etemadi
Postdoctoral Scholar, Nephrology
Current Research and Scholarly InterestsI am a clinician and data scientist focusing on drawing causal inferences from observational data when randomized controlled trials are not feasible. Currently, my work centers on patients with late-stage chronic kidney disease, a rapidly growing population for which evidence is limited due to their frequent exclusion from RCTs. At the moment, I aim to move towards precision medicine approaches to optimize outcomes for these patients.
-
Markus Eyting
Postdoctoral Fellow, Medicine - Primary Care and Population Health
BioI am an applied microeconomist, using experimental methods as well as survey and administrative data to study the interplay of beliefs and individual decision-making with applications to health, discrimination, and machine learning.
For more information, please visit my website: https://meyting.com/. -
Robert Michael Fairchild
Assistant Professor of Medicine (Immunology and Rheumatology)
Current Research and Scholarly InterestsDr. Fairchild’s research focuses on musculoskeletal and organ-based ultrasound in rheumatic disease, including arthritis, calcinosis, vascular pathology, and interstitial lung disease. He develops ultrasound-based outcome measures and leads projects applying deep learning and explainable AI to imaging. He also performs ultrasound-guided synovial biopsies to support translational and clinical research.
-
Bita Fakhri, MD, MPH
Associate Professor of Medicine (Hematology)
BioDr. Bita Fakhri is an Associate Professor of Medicine in the Division of Hematology at Stanford University School of Medicine. She specializes in the treatment of chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL), hairy cell leukemia, Richter’s syndrome, and other hematologic malignancies.
As a clinical scientist, Dr. Fakhri is dedicated to patient care, trainee education, and the development of novel therapies for individuals with CLL/SLL. She has co-authored numerous publications focusing on CLL, targeted therapies, and cellular therapies in hematologic malignancies.
Dr. Fakhri currently serves as Director of the CLL Clinical Trial Portfolio at Stanford. In addition, she is actively involved in building infrastructure to expand access to clinical trials and promote equity in care for underserved and marginalized populations across the Stanford catchment area. -
Titilola Falasinnu
Assistant Professor of Medicine (Immunology and Rheumatology) and, by courtesy, of Anesthesiology, Perioperative and Pain Medicine (Adult Pain)
BioI am primarily a lupus researcher and identify as a pain scientist and methodologist in this field. Systemic lupus erythematosus (SLE) disproportionately affects women and racial minorities and is the fifth most common cause of death among 15- to 24-year-old Black and Hispanic women in the U.S., highlighting its significant public health impact. More than half of patients with SLE experience chronic pain, often secondary to SLE itself or overlapping conditions (e.g., migraines, low back pain, fibromyalgia), contributing significantly to disability and impaired quality of life. Chronic pain is not merely a symptom but a disease in its own right—one that deserves the same rigorous study and clinical attention as comorbidities like kidney disease and cardiovascular disease in rheumatology. The enormous global burden of chronic pain underscores the urgent need for a clear, standardized definition of pain as a disease, particularly in autoimmune rheumatic diseases where pain can arise from inflammatory, nociplastic, and biopsychosocial mechanisms. Without recognizing pain as a distinct disease entity, its mechanisms remain poorly understood, and effective treatment strategies remain underdeveloped.
I am a co-Principal Investigator of the Pain Intelligence Lab, where our mission is to advance the study of pain as a disease in rheumatology through two primary objectives. First, we develop and validate computational methods that enable clinicians and researchers to leverage electronic health records, administrative claims, and disease registries to study chronic pain as a distinct disease entity in rheumatology. By applying machine learning, natural language processing, and real-world data analysis, we seek to enhance pain phenotyping, classify distinct pain subtypes, and develop predictive models for treatment response. Second, we use a biopsychosocial framework to examine the predictive power of biomarkers and psychosocial measures in rheumatologic pain. By integrating biological, psychological, and social determinants of pain, we aim to conduct rigorous, patient-oriented research that translates targeted assessments into mechanistically informed, personalized treatment approaches for optimized clinical care. Ultimately, my long term career goal is to bridge the gap between research and clinical practice, ensuring that pain management in autoimmune rheumatic diseases is precise, equitable, and optimized for improved patient outcomes. -
Alice C. Fan
Associate Professor of Medicine (Oncology) and, by courtesy, of Urology
Current Research and Scholarly InterestsDr. Fan is a physician scientist who studies how turning off oncogenes (cancer genes) can cause tumor regression in preclinical and clinical translational studies. Based on her findings, she has initiated clinical trials studying how targeted therapies affect cancer signals in kidney cancer and low grade lymphoma. In the laboratory, she uses new nanotechnology strategies for tumor diagnosis and treatment to define biomarkers for personalized therapy.
-
Daniel Z Fang
Affiliate, Med/Hospital Medicine
BioDaniel Z Fang, MD, FACP completed his medical school training at UC San Diego School of Medicine and residency at Stanford University. He is a board-certified academic hospitalist at the VA Palo Alto Health Care System and Clinical Associate Professor (Affiliated) within the Stanford Division of Hospital Medicine.
As Assistant DCOS for Acute Care Hospital Operations, he provides administrative and clinical guidance to clinical service staff in the areas of inpatient performance, patient flow optimization, policy review, project planning, and process improvement initiatives. His professional interests include healthcare administration and quality improvement. -
Diana Farid
Clinical Associate Professor, Medicine - Vaden Health Center
BioDiana Farid MD, MPH is a physician, filmmaker, an award-winning author and poet. She is a Clinical Associate Professor in the Department of Medicine and Faculty in the Medical Humanities and Arts Program at Stanford's School of Medicine. After earning a BA in Peace and Conflict Studies at UC Berkeley, MD at Northwestern University, and Family Medicine specialty training at UCLA, she was awarded a U.S. Department of Health and Human Services Child and Family Health Leadership Fellowship, during which she earned a Masters in Public Health focused on community health and storytelling.
Since then, Diana has continued to care for patients while creating and championing the vital role of story and the arts in medicine and health. After serving as a physician consultant for television shows like Grey's Anatomy, she produced the feature length documentary film, American Rhythms, exploring the positive impact of music on elementary school student health. At Stanford, she has integrated medicine and the mediums of film, creative writing, and poetry into student and community experiences while leading and presenting arts programs across Stanford. As Assistant Director of Stanford School of Medicine’s Program in Bioethics and Film, she produced film screenings and panel discussions exploring films with vital bioethical implications. She established the first Stanford Film and Medicine Interest group for medical students to study film as a health promotion tool and has mentored medical student film projects. She produced the Stanford Medicine and the Muse, Medical Humanities and the Arts' 2018 Frankenstein@200 year-long cross-campus film screening and panel series.
Her poetry has been featured in gallery exhibits, storytelling events, anthologies, and journals. Her multi-award-winning picture book, When You Breathe (Abrams), melds respiratory science with poetry. Her novel written in verse, Wave (Abrams), celebrating medicine, music and poetry and noted as “Raw and powerful…Rich, layered and heart-rending” — Kirkus, has won numerous awards including the Cybils Award for Novel in Verse, was named a Best Middle Grade Book of 2022 by the School Library Journal, and is on state education board reading lists across the United States. Her latest picture book, The Light of Home (Scholastic) is a lyrical story about painting and belonging. Her debut board book Already All the Love (Little Bee Books) is a poem for presence. She is an Editorial Board Member for poetry for the medical humanities journal, The Pharos. In 2025, she created a first-of-its-kind Women in Medicine participatory poem for the Stanford School of Medicine. In 2026, she is co-teaching Peds 129: Little Libraries: Improving Children’s Literacy through Service and Storytelling. For 2025-2026, she is one of the inaugural artsCatalyst Fellows of the Stanford Arts Institute. -
Charles J. Faselis
Professor of Medicine (Hospital Medicine)
Current Research and Scholarly InterestsMy research interests focus on the use of large clinical datasets to better understand factors associated with health and disease. Current work includes studies of cardiorespiratory fitness, aging, chronic disease, healthcare access, appointment adherence and their relationship to health outcomes, and the application of artificial intelligence and machine learning to improve clinical outcomes and healthcare delivery, particularly among Veterans.
-
C. Garrison Fathman
Professor of Medicine (Immunology and Rheumatology), Emeritus
Current Research and Scholarly InterestsMy lab of molecular and cellular immunology is interested in research in the general field of T cell activation and autoimmunity. We have identified and characterized a gene (GRAIL) that seems to control regulatory T cell (Treg) responsiveness by inhibiting the Treg IL-2 receptor desensitization. We have characterized a gene (Deaf1) that plays a major role in peripheral tolerance in T1D. Using PBC gene expression, we have provisionally identified a signature of risk and progression in T1D.
-
William Fearon, MD
Professor of Medicine (Cardiovascular Medicine)
Current Research and Scholarly InterestsDr. Fearon's general research interest is coronary physiology. In particular, he is investigating invasive methods for evaluating the coronary microcirculation. His research is currently funded by an NIH R01 Award.
-
David Feldman
Professor of Medicine (Endocrinology, Gerontology and Metabolism), Emeritus
Current Research and Scholarly InterestsStudies of the role of the vitamin D receptor in the action of 1,25-dihydroxyvitamin D, the active vitamin D hormone. Current efforts are evaluating the vitamin D receptor in breast and prostate cancer, osteoporosis and rickets.
-
Dean W. Felsher
Professor of Medicine (Oncology) and of Pathology
Current Research and Scholarly InterestsMy laboratory studies the molecular basis of cancer with a focus on understanding when cancer can be reversed through targeted oncogene inactivation.
-
Jessica Ferguson Toll
Clinical Assistant Professor, Medicine - Infectious Diseases
BioDr. Ferguson is a board certified Infectious Disease specialist. She specializes in the treatment of immunocompromised patients, including patients who have undergone bone marrow or solid organ transplantation and patients with hematologic or solid malignancies on chemotherapy.
-
Nielsen Fernandez-Becker
Clinical Professor, Medicine - Gastroenterology & Hepatology
BioI am the director of the Celiac Disease Program at Stanford and I am highly experienced in diagnosis and management of celiac disease and gluten associated disorders.
My objective is to provide excellent and compassionate clinical care for my patients while seeking a better understanding of diseases I treat, particularly Celiac disease (CeD), eosinophilic esophagitis (EoE). My top priorities are patient care and translational research to make new discoveries and improve the care my patients. -
Priya Fielding-Singh
Postdoctoral Scholar, SCRDP/ Heart Disease Prevention
BioI am a Sociologist and Postdoctoral Fellow in Cardiovascular Disease Prevention at the Stanford Prevention Research Center. My research examines health, gender, and social inequality.
My primary research agenda investigates health disparities across class, race, and gender in the United States. I draw on both qualitative and quantitative methods to understand how neighborhoods, schools, and families shape our health behaviors and outcomes. My work has been published in journals such as Social Science & Medicine, Obesity, Sociological Science, and the Journal of Adolescent Health.
I hold a Ph.D. in Sociology from Stanford University, a M.A. in Anthropology from the University of Bremen, and a B.S. in Education and Social Policy from Northwestern University. -
George A. Fisher Jr.
Colleen Haas Chair in the School of Medicine, Emeritus
Current Research and Scholarly InterestsClinical expertise in GI cancers with research which emphasizes Phase I and II clinical trials of novel therapies but also includes translational studies including biomarkers, molecular imaging, tumor immunology and development of immunotherapeutic trials.
-
Daniel Owen Fishman
Clinical Assistant Professor, Psychiatry and Behavioral Sciences - Medical Psychiatry
Clinical Assistant Professor (By courtesy), Medicine - Blood & Marrow TransplantationBioAfter graduating from Vanderbilt Medical School, Dr. Fishman completed the Psychiatry Residency Program at University of Pittsburgh Medical Center, where he served as Chief Resident and was lauded with the program’s sole Teaching Award. Thereafter, Dr. Fishman completed the Consultation-Liaison Psychiatry Fellowship also at the University of Pittsburgh Medical Center. During his training, he also served as Chief Fellow was elected into Alpha Omega Alpha, Honors Medical Society. In the subsequent years, Dr. Fishman practiced as a consultation and liaison psychiatrist, simultaneously serving both academic and community hospitals in the Greater Pittsburgh Area. In his outpatient clinic, he managed and treated patients with complex issues linking the domains of neurology and psychiatry, and specialized in nonepileptic episodes.
Dr. Fishman joined the faculty of Stanford University School of Medicine in 2020 as a Clinical Assistant Professor of Psychiatry and Behavioral Sciences. Since his appointment, Dr. Fishman has led medical psychiatry services on the medical/surgical units, intensive care units and in the emergency department at Stanford Hospital to provide psychiatric care for patients with acute diagnoses and provide graduate medical education to psychiatry, internal medicine, palliative care, oncology, and neurology trainees. His work on developing a framework for evidence-based best practice guidelines was recognized with a 2020 DLIN/Fischer finalist award.
Dr. Fishman is the appointed Chief of the Inpatient Proactive Psycho-Oncology Service, a service designed to proactively identify patients with psychopathology or who will require psychiatric intervention during their hospitalization. The service helps prevent development and escalation of psychopathology in the inpatient blood and marrow transplant and other cancer populations. His outpatient work is primarily as a psychiatric oncologist at the Stanford Cancer Center where he provides psychiatric consultation services and collaborates closely with his oncology colleagues to deliver comprehensive cancer care.
His clinical and scholarly interests include the interface of medicine and psychiatry, psycho-oncology, catatonia, neuropsychiatry, collaborative care models, psychotherapy for the medically ill, interdisciplinary and graduate medical education. -
Peter Fitzgerald, MD, PhD
Professor (Research) of Medicine (Cardiovascular), Emeritus
BioDr. Peter Fitzgerald is the Director of the Center for Cardiovascular Technology and the Cardiovascular Core Analysis Laboratory (CCAL) at Stanford University School of Medicine. He is an interventional cardiologist and holds a PhD in engineering. He is a professor in both the Department of Medicine and the Department of Engineering (by courtesy) at Stanford.
Dr. Fitzgerald has led or participated in more than 175 clinical trials, has published more than 550 manuscripts and book chapters, and lectures worldwide. Over the past two decades, he has trained more than 150 postdoctoral researchers in engineering and medicine. Most recently, Dr. Fitzgerald completed two years of study toward a master’s degree focused on machine learning and agentic principles supporting AI.
Dr. Fitzgerald has been a principal founder of 24 medical startups in the San Francisco Bay Area and has transitioned 17 of them to large medical device companies. He serves on several boards of directors and advises dozens of medical device startups, as well as multinational healthcare companies, on the design and development of new diagnostic and therapeutic devices in the cardiovascular arena. In 2001, Dr. Fitzgerald was part of the founding team of LVP Capital, a venture firm focused on medical device and biotechnology startups in San Francisco. In 2010, he co-founded Triventures, an early-stage medical technology fund with offices in Palo Alto and Tel Aviv. -
Annesa Flentje
Professor (Research) of Medicine (Stanford Prevention Research Center)
BioAnnesa Flentje, PhD, is a Professor at Stanford University in the Stanford Prevention Research Center, Department of Medicine, School of Medicine. Dr. Flentje is a clinical psychologist who uses multiple methods to understand the impacts of stress and coping on human health and disease. Her research has investigated how stress directly impacts health outcomes and how these processes are mediated through both behaviors (e.g., substance use and coping) and molecular mechanisms (e.g., epigenetics and transcriptional regulation). Dr. Flentje has developed cognitive behavioral interventions to reduce stress, and identified these as a mechanism to alter immune pathways in gene expression. Dr. Flentje is currently leading a large comparative effectiveness study of two interventions for posttraumatic stress symptoms among LGBTQIA+ populations in California. Dr. Flentje has developed and led nationwide mentoring initiatives to support health research of understudied populations and translational research to improve health. Dr. Flentje is Co-Director of The PRIDE Study (pridestudy.org), a national longitudinal cohort study of LGBTQIA+ individuals within the United States that has enrolled over 30,000 participants and is approaching 10 years of data collection.
-
Shawna Follis
Instructor, Epidemiology and Population Health
Affiliate, Med/SPRC - DivisionBioShawna Follis, PhD, MS, is an Instructor and K99 Fellow in Epidemiology, researching the risk factors of cardiometabolic diseases. She completed her postdoctoral training at Stanford, as a Propel Postdoctoral Scholar from 2021 to 2023 and a NIH T32 Postdoctoral Fellow from 2020 to 2021. She received her PhD in epidemiology at the University of Arizona and her master’s degree in anthropology from Purdue University.
